Navigation Links
During Olympics, Cornell's Max Zhang studies air-quality in Beijing
Date:7/22/2008

zed he could use the city as a laboratory to see if the efforts would work and to what extent.

Zhang and graduate student Xing Wang traveled to Beijing in the summer of 2007 to take initial measurements of airborne particles in various spots around the city, from heavily trafficked highways to residential communities -- even inside restaurants. They used real-time analytical instruments to capture the changes in particle size and concentrations in a matter of seconds.

Zhang plans to repeat tests in Beijing during the Olympics, and then again a year later. The study is supported by Cornell's Jeffrey Sean Lehman Fund for Scholarly Exchange with China and the U.S. Environmental Protection Agency.

Zhang also is collaborating in an air quality project in Syracuse, N.Y., helping to design a controlled ventilation system for a building to be placed at the intersection of Interstates 81 and 690 -- a major hub in downtown Syracuse. The building will house the Syracuse Center of Excellence in Environmental and Energy Systems, which is funding the study.

The ventilation's control system would turn up or down, depending on the quality of air around the building at any given time. To design it, Zhang is using cameras to measure traffic levels. He is developing computer algorithms to simulate how the plume of pollution would disperse into the building.

"I think it's novel in terms of linking the building to the surrounding environment," he said. "When people think about a building, they only think about the building alone. They never think, 'The building has to be somewhere.'"

Zhang is excited at the opportunity to work on such a project, because he has long studied traffic dispersion and how it relates to the air people breathe.

"The cities are my laboratory," he said.

He also is working on air quality studies in Rochester and in South Bronx, N.Y., where high rates of asthma in schoolchildren are believed to
'/>"/>

Contact: Blaine Friedlander
bpf2@cornell.edu
607-254-8093
Cornell University Communications
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Consumption of nut products during pregnancy linked to increased asthma in children
2. VaxInnate to discuss seasonal and pandemic flu vaccines during BIO 2008 this week
3. National Science Foundation funds research addressing enduring questions of life
4. Exercise during pregnancy leads to a healthier heart in moms- and babies-to-be
5. Computers explain why pears may become brown during commercial storage
6. Antarctic life hung by a thread during ice ages
7. USC researchers identify mechanism that controls activation of stem cells during hair regeneration
8. Moms obesity during conception phase may set the stage for offsprings obesity risk
9. Intravenous gene therapy protects normal tissue of mice during whole-body radiation
10. Amazon forest shows unexpected resiliency during drought
11. Low vitamin D during pregnancy linked to pre-eclampsia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...LPHIA Now in its 32nd year, the CTRC-AACR San Ant...the best in breast cancer science and world leader...icating breast cancer. , This year, more than 8...r at the Henry B. Gonzales Convention Center in Sa... partnership between the American Association for ...
(Date:12/3/2009)...u ever felt overly upset by a social snubbing? You... Scientists have long known that opium-like painki...ain, but also some forms of emotional stress. Now,...ember Markus Heilig shows that small genetic diffe...ermine the intensity of people,s responses to soci...
(Date:12/3/2009)...NY A team of scientists from the U.S. Department ...Harvard University, and the Indian Institute of Sc...olecules locate the genetic information in DNA tha...rocesses. The research, published in the December ...Biology , confirms that many proteins responsible ...
Breaking Biology News(10 mins):CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2Grooving down the helix 2Grooving down the helix 3Sun Life Family Health Center Adopts InteGreat EHR 28TM 29 for Implementation of Browser Based EHR 58262 1Sun Life Family Health Center Adopts InteGreat EHR 28TM 29 for Implementation of Browser Based EHR 58262 2Sun Life Family Health Center Adopts InteGreat EHR 28TM 29 for Implementation of Browser Based EHR 58262 3Symmetry Medical to Present at JMP Securities Healthcare Focus Conference 58257 1Symmetry Medical to Present at JMP Securities Healthcare Focus Conference 58257 2MAQUET Cardiovascular Announces Leading Robotic Heart Surgeon Performs First Beating Heart Fully Endoscopic Bypass Surgery Using Miniaturized Cardiopu 14258 1MAQUET Cardiovascular Announces Leading Robotic Heart Surgeon Performs First Beating Heart Fully Endoscopic Bypass Surgery Using Miniaturized Cardiopu 14258 2MAQUET Cardiovascular Announces Leading Robotic Heart Surgeon Performs First Beating Heart Fully Endoscopic Bypass Surgery Using Miniaturized Cardiopu 14258 3MAQUET Cardiovascular Announces Leading Robotic Heart Surgeon Performs First Beating Heart Fully Endoscopic Bypass Surgery Using Miniaturized Cardiopu 14258 4
... On November 1415, over 40 scientists will convene...llbrook, New York to discuss the future of biofuel...l include some of our nations leading biofuel expe...sity), Charles Hall (SUNY-ESF), and G. Philip Robe...l have been touted as sustainable alternatives to ...
... For more than 40 years, researchers have suspect...ly flush sodium out of the body and could be harne...s for high blood pressure, or hypertension. Curren...us side effects because they also reduce potassium...mpson Institute for Plant Research (BTI) have used...
... MOSCOW/POST FALLS, Idaho University of Idaho re...ounds to develop more effective defenses against S...hogens. , One of the goals of that effort is to...on of strains resistant to the antibiotic methicil...ylococcus aureus, or MRSA. , Breakthrough detecti...
Other Biology News:Can plant-based ethanol save us from our fossil fuel addiction? 2Researchers' discovery may lead to hypertension treatment 2Developing kryptonite for Superbug 2Developing kryptonite for Superbug 3Developing kryptonite for Superbug 4Developing kryptonite for Superbug 5
(Date:12/3/2009)... , HOUSTON, Dec. 3 JourneyL...pdated its facility to offer patients a second sur... with the LAP-BAND® System that it currentl... at the facility was performed by surgeon partner,...e patient is reported as doing well. ,, The Ver...
(Date:12/3/2009)..., PHILADELPHIA, Dec. 3 /PRNewswire-FirstCall/ -...l specialty biopharmaceutical company, today annou... market withdrawal of one lot of the Attention-Def...® . Shire is taking this action because some ...not meet their release liner removal specification...
(Date:12/3/2009)... , NEW DELHI, India, Dec. 3 /PRNewswi...ience Officer at Shenzhen Beike Biotechnology Co. ...conference on High-Risk Diabetic,Foot Care in New ...leading,stem cell research and regenerative medici...y the Indian Podiatry Association (IPA), aimed,to ...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Report...port is available in its catalogue: ,, Carbond..., http://www.reportlinker.com/p0164368/Carbond...ml ,, Incubators are the most critical equipm...ch, and other applications for providing a control...
Breaking Biology Technology:JourneyLite of Houston Now Offering Sleeve Gastrectomy 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4
...Call/ - Dragon Pharmaceutical Inc.,(TSX: DDD; OTCB...results,for the second quarter ended June 30, 2007...les increased 48% to $20.55 million from $13.89 mi...sed 19% as compared to the first quarter 2007... $3.98 million and 19.36% from $2.39 million ...
... XTL,Biopharmaceuticals Ltd. (NASDAQ: XTLB ; LSE:...ged in the acquisition, development and,commercial... medical needs,particularly neuropathic pain and h...for the six months ended June 30, 2007. At June 3...d short-term,bank deposits of $12.6 million, compa...
...peutics,Inc. (Nasdaq: CVTX ) announced today that... College of Cardiology Foundation and the American...sue of Circulation, state that,"ranolazine may be ...TEMI." Ranexa(R) (ranolazine extended-release tab...gina in patients who have not achieved an adequate...
Other Biology Technology:Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007 2Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007 3XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 2XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 3XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 4XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 5XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 6XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 7XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 8XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 9XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 10XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 11XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 12XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 13XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007 14Ranexa(R) Added to New ACC/AHA Guidelines on Unstable Angina/Non ST-Elevation Myocardial Infarction (UA/NSTEMI) 2
Rat Anti-Mouse Serpin F1 / PEDF Monoclonal Antibody, Unconjugated, Clone 199315 from R&D Systems
Rat Anti-HP1 gamma Monoclonal Antibody, Unconjugated, Clone MAC385 from ABR-Affinity BioReagents
Prostaglandin E2 Luminex Standard from Cayman Chemical
Eppendorf tube holder, for Tube rack 175 x 12 mm from GE Healthcare, formerly Amersham Biosciences
Biology Products: